These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6466255)
21. The effect of acetazolamide on the proteinuria of altitude. Bradwell AR; Delamere JP Aviat Space Environ Med; 1982 Jan; 53(1):40-3. PubMed ID: 7034715 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711 [TBL] [Abstract][Full Text] [Related]
23. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis. Kayser B; Dumont L; Lysakowski C; Combescure C; Haller G; Tramèr MR High Alt Med Biol; 2012 Jun; 13(2):82-92. PubMed ID: 22724610 [TBL] [Abstract][Full Text] [Related]
24. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963 [TBL] [Abstract][Full Text] [Related]
25. Acetazolamide does not alter endurance exercise performance at 3,500-m altitude. Bradbury KE; Yurkevicius BR; Mitchell KM; Coffman KE; Salgado RM; Fulco CS; Kenefick RW; Charkoudian N J Appl Physiol (1985); 2020 Feb; 128(2):390-396. PubMed ID: 31804890 [TBL] [Abstract][Full Text] [Related]
26. Intraocular pressure is not associated with acute mountain sickness. Cushing T; Paterson R; Haukoos J; Harris NS High Alt Med Biol; 2013 Dec; 14(4):342-5. PubMed ID: 24377341 [TBL] [Abstract][Full Text] [Related]
27. Acute mountain sickness prophylaxis: a high-altitude perspective. DeLellis SM; Anderson SE; Lynch JH; Kratz K Curr Sports Med Rep; 2013; 12(2):110-4. PubMed ID: 23478562 [TBL] [Abstract][Full Text] [Related]
28. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. Kayser B; Hulsebosch R; Bosch F High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216 [TBL] [Abstract][Full Text] [Related]
29. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile. Moraga FA; Flores A; Serra J; Esnaola C; Barriento C Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292 [TBL] [Abstract][Full Text] [Related]
30. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up. McDevitt M; McIntosh SE; Rodway G; Peelay J; Adams DL; Kayser B Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065 [TBL] [Abstract][Full Text] [Related]
31. Effect of high terrestrial altitude and supplemental oxygen on human performance and mood. Crowley JS; Wesensten N; Kamimori G; Devine J; Iwanyk E; Balkin T Aviat Space Environ Med; 1992 Aug; 63(8):696-701. PubMed ID: 1510643 [TBL] [Abstract][Full Text] [Related]
32. [Incidence, prevention and therapy of acute mountain sickness]. Oelz O Schweiz Med Wochenschr; 1982 Apr; 112(14):492-5. PubMed ID: 7079685 [TBL] [Abstract][Full Text] [Related]
33. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. Latshang TD; Nussbaumer-Ochsner Y; Henn RM; Ulrich S; Lo Cascio CM; Ledergerber B; Kohler M; Bloch KE JAMA; 2012 Dec; 308(22):2390-8. PubMed ID: 23232895 [TBL] [Abstract][Full Text] [Related]
34. Acute mountain sickness impact among travelers to Cusco, Peru. Salazar H; Swanson J; Mozo K; White AC; Cabada MM J Travel Med; 2012 Jul; 19(4):220-5. PubMed ID: 22776382 [TBL] [Abstract][Full Text] [Related]
35. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
36. Cognitive changes at high altitude in healthy climbers and in climbers developing acute mountain sickness. Regard M; Landis T; Casey J; Maggiorini M; Bärtsch P; Oelz O Aviat Space Environ Med; 1991 Apr; 62(4):291-5. PubMed ID: 2031628 [TBL] [Abstract][Full Text] [Related]
37. Acute mountain sickness in travelers who consulted a pre-travel clinic. Croughs M; Van Gompel A; Van den Ende J J Travel Med; 2011; 18(5):337-43. PubMed ID: 21896098 [TBL] [Abstract][Full Text] [Related]